MBCE
Monarch Blue Chips Elite ETF
Monarch Blue Chips Elite ETF seeks to provide long-term capital appreciation by investing primarily in large-cap companies with strong fundamentals and a proven track record of performance.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 197.0 M
ASSETS UNDER MGMT
101 bp
EXPENSES
Fund Basics
| Inception date | Mar 23, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ADVANCED MICRO DEVICES | 9.1 % |
| MICROSOFT CORP | 5.0 % |
| TEXAS INSTRUMENTS INC | 5.0 % |
| ELI LILLY & CO | 4.9 % |
| APPLE INC | 4.8 % |
| VISA INC. CLASS A | 4.8 % |
| MASTERCARD INCORPORATED CLASS A | 4.6 % |
| AMAZON.COM INC | 4.6 % |
| PALANTIR TECHNOLOGIES INC. CLASS A | 4.5 % |
| AMGEN INC | 4.3 % |
Constituent Breakdown
| Number of holdings | 24 |
| Herfindahl-Hirschman Index | 454 |
| Wgt avg mkt cap (mns) | $1,173,500 |
| Large cap (>$10bn) | 99.8% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
| UNITED STATES | 99.8 % |
Historical Performance
Standardized Performance (as of 10/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -2.8% | -2.7% | 2.6% | 11.8% | 3.9% | -- | -- | 7.0% |
| Dividend Yield | 0.2% | 0.3% | 0.3% | 0.2% | 0.1% | -- | -- | 0.1% |
| Total Returns | -2.6% | -2.4% | 2.9% | 12.0% | 4.1% | -- | -- | 7.1% | Ann. Volatility | 26.0% | 24.1% | 21.3% | 18.7% | 19.5% | -- | -- | 18.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.53 | 61% |
| MSCI EAFE | 0.99 | 38% |
| MSCI Emg Mkts | 0.79 | 61% |
Liquidity Measures
| Avg. volume (000) | 22 |
| ADV traded (mns) | $1 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.11% |
Technical Indicators
| 30d moving avg. (EMA) | $36.66 |
| Relative strength (RSI) | 44 |
| MACD/Signal | -1.02/-0.74 |
| Bollinger Bands (Upper/Lower) | $39.37/$33.29 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MBCE |
Expenses vs. MBCE |
ALTAR Score™ vs. MBCE |
|---|---|---|---|---|
| PJFG | PGIM Jennison Focused Growth ETF | 46.8% | -26 bp | -0.9% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 45.0% | -71 bp | -0.5% |
| USMC | Principal U.S. Mega-Cap ETF | 44.1% | -89 bp | +0.4% |
| RND | First Trust Bloomberg R&D Leaders ETF | 43.2% | -41 bp | +0.4% |
| GGRW | Gabelli Growth Innovators ETF | 42.7% | -11 bp | -0.5% |
| QLTY | GMO U.S. Quality ETF | 42.2% | -51 bp | +0.6% |
| IWFG | IQ Winslow Focused Large Cap Growth ETF | 42.0% | -7 bp | -0.6% |
| BBLU | EA Bridgeway Blue Chip ETF EA Bridgeway Blue Chip ETF | 41.3% | -86 bp | +0.9% |
| GROZ | Zacks Focus Growth ETF | 40.9% | +13 bp | 0.0% |
| QTOP | iShares Nasdaq Top 30 Stocks ETF | 40.6% | -81 bp | +0.2% |
Risk and Returns: MBCE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/15/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.2%
ALTAR SCORE™
26th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,440 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. MBCE's ALTAR Score™ is approximately -0.6 standard
deviations above the category average. This places MBCE in the 26th percentile
among funds in the category.
Sell-Side Consensus
$41.73
PRICE TARGET
+17.2%
UPSIDE